Moberg Pharma AB (publ)Stockholm
LEI 549300XFXK7DVGDRP410 · XSTO · SE · Business ID 556697-7426
Recent insider sentiment
Net buying — last 90 days
SEK 106,900.00 boughtNo sales
Share-award batches are excluded from this read — they’re compensation, not conviction.
1
Open-market buys (90d)
0
Sales (90d)
3
Share awards (90d)
4
Active insiders (90d)
Transactions
| Date | Person | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 07.07.2026 | Mark Beveridge — CFO | Share award | 11,201 | — | Share award 11,201 shares | ↗ |
| 07.07.2026 | Share award | 19,693 | — | Share award 19,693 shares | ↗ | |
| 07.07.2026 | Annika Christine Magnusson — Management | Share award | 11,816 | — | Share award 11,816 shares | ↗ |
| 22.05.2026 | Lars Johansson — Board member | Bought — open marketAcquisition | 10,000 | SEK 10.69 | SEK 106,900.00 | ↗ |
Active insiders (90d)
19,693 shares
1 filing
Annika Christine Magnusson
Management
11,816 shares
1 filing
11,201 shares
1 filing
Lars Johansson
Board member
10,000 shares
1 filing